|
|
85 Main Street
Hopkinton, MA 01748 USA
phone:(508) 497-2300
fax:(508) 497-9553
|
|
| Symbol |
private |
| Founded |
1994 |
| Employees |
|
|
|
| www.aderis.com
|
|
| Research Sector |
Healthcare Services |
|
 |
| Summary Description |
| Small molecule therapeutics for CNS, cardiovascular and renal diseases. |
|
| Management |
| Kenneth L. Rice Jr., M.B.A., J.D., Vice President, CFO, and Chief Commercial Officer; William S. Wheeler, M.D., Vice President and Chief Medical Officer; James V. Peck, Pharm D., Vice President of Research Operations; Noel J. Cusack, Ph.D., Vice President and Chief Scientific Officer; Gevork Minaskanian, Ph.D., Vice President of Chemistry |
| |
|
|
| |
|
| Keywords |
| CNS, cardiovascular, renal diseases, small molecule, nervous system, inflammatory |
|
|
|
| Description |
|
Aderis Pharmaceuticals is a biopharmaceutical company engaged in developing small molecule drugs to treat central nervous system, cardiovascular and inflammatory conditions. The company currently has four product candidates in development. |
|
|
| Strategy |
Adeirs Pharmaceuticals has corporate alliances with Schwarz Pharma AG for worldwide development and commercialization of Rotigotine CDS; King Pharmaceuticals for licensing and commercialization of Aderis' adenosine A2A agonists and Fujisawa Healthcare for development and commercialization in the United States and Canada of the IV formulation of selodenoson.
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members